Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q4 | -0.23 | $0 | -$3M |
| 2025 Q3 | -0.36 | $0 | -$3M |
| 2025 Q2 | -1.38 | $0 | -$3M |
| 2025 Q1 | -1.07 | $0 | -$3M |
| 2025 Q4 | -1.81 | $0 | -$3M |
| 2024 Q3 | -1.46 | $0 | -$2M |
| 2024 Q2 |
| -2.47 |
| $0 |
| -$2M |
| 2024 Q1 | -0.14 | $0 | -$2M |